C4U and Noile-Immune Biotech partnership on PRIME allogeneic CAR-T cell therapy

Noile-Immune Biotech Inc., (“Noile-Immune”) and C4U Corporation, (“C4U”) announced that they have entered into an agreement on joint research and commercialization of next-generation allogeneic gene-modified immune cell therapy combining C4U’s CRISPR/Cas3 genome editing technology and Noile-Immune’s PRIME (Proliferation inducing and migration enhancing) technology designed to improve proliferation and trafficking of immune cells into solid tumors.…

Details

Celebrate Fourth of July Safely

This year, Fourth of July revelers will have to swap many traditions — peppy parades, large family reunions and patriotic concerts — with low-key celebrations. But there are plenty of safe ways to commemorate America’s birthday. Here are some suggestions. Watch fireworks, in person or onscreen. Many cities have canceled their festivities, and with that,…

Details